James S. Myerson

Sign up to set email alerts
|
30Publications
249Citation Statements Received
267Citation Statements Given
How they've been cited
396
5
243
1
How they cite others
359
3
264
0
Publications
Order By: Most citations

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Abani1,
Abbas2,
Abbas3
et al. 2022
The Lancet
167
1
83
0
2
View full textAdd to dashboardCite

Treatment options for small cell lung cancer – do we have more choice?

Puglisi
1
,
Dolly
2
,
Faria
3
et al. 2010
Br J Cancer
96
0
65
0
View full textAdd to dashboardCite
show abstract

A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma

Minchom
1
,
Punwani
2
,
Filshie
3
et al. 2016
European Journal of Cancer
36
0
34
0
View full textAdd to dashboardCite

A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks

O’Brien
1
,
Myerson
2
,
Coward
3
et al. 2012
European Journal of Cancer
25
2
16
0
View full textAdd to dashboardCite

Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy

Brunetto
1
,
Carden
2
,
Myerson
3
et al. 2010
Journal of Thoracic Oncology
20
1
17
1
View full textAdd to dashboardCite
show abstract

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Abani1,
Abbas2,
Abbas3
et al. 2023
The Lancet
37
1
17
0
View full textAdd to dashboardCite

Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations

Trani
1
,
Myerson
2
,
Ashley
3
et al. 2010
Lung Cancer
5
0
5
0
View full textAdd to dashboardCite

Chronic obstructive pulmonary disease in lung cancer – underdiagnosed and undertreated

Myerson1,
Priest2,
Power3
et al. 2009
Lung Cancer
1
0
2
0
View full textAdd to dashboardCite
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.